Author: Alkhateeb, Khaled J.; Cahill, Meredith N.; Ross, Adam S.; Arnold, Forest W.; Snyder, James W.
Title: The reliability of saliva for the detection of SARS-CoV-2 in symptomatic and asymptomatic patients: Insights on the diagnostic performance and utility for COVID-19 screening Cord-id: qfwj1l6c Document date: 2021_6_6
ID: qfwj1l6c
Snippet: Current literature has focused on testing saliva in symptomatic patients, and little information is available regarding saliva performance in asymptomatic SARS-CoV-2 infection. We compared paired saliva and nasopharyngeal swabs (NPS) collected from 33 symptomatic and 12 asymptomatic known SARS-CoV-2-positive patients. Saliva had an overall sensitivity of 59%, a specificity of 95%, and a negative predictive value of 98%. Saliva demonstrated higher sensitivity in symptomatic (80%) vs. asymptomatic
Document: Current literature has focused on testing saliva in symptomatic patients, and little information is available regarding saliva performance in asymptomatic SARS-CoV-2 infection. We compared paired saliva and nasopharyngeal swabs (NPS) collected from 33 symptomatic and 12 asymptomatic known SARS-CoV-2-positive patients. Saliva had an overall sensitivity of 59%, a specificity of 95%, and a negative predictive value of 98%. Saliva demonstrated higher sensitivity in symptomatic (80%) vs. asymptomatic individuals (36%) (P=0.006), and in high-risk (symptomatic, febrile and/or with comorbidities) (82%) vs. low-risk (asymptomatic, afebrile and no comorbidities) (22%) patients (P=0.0002). Cycle threshold (Ct) values in NPS specimens were higher in saliva-negative vs. saliva-positive cases (P= 0.02 and <0.001). Overall, these findings show that despite saliva's low sensitivity in asymptomatic SARS-CoV-2 infections, it can detect infections with lower Ct values and a potentially higher chance of viral transmission. Additional studies are warranted to fully evaluate saliva as a screening test for COVID-19.
Search related documents:
Co phrase search for related documents- abdominal pain and acute respiratory sars syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abdominal pain and low infection: 1, 2, 3
- accuracy negative predictive value and acute respiratory sars syndrome: 1, 2, 3, 4, 5, 6, 7
- accuracy negative predictive value and low infection: 1, 2
- active infection and acute respiratory sars syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active infection and admission screening: 1, 2
- active infection and low infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active infection and low infection prevalence: 1, 2, 3, 4, 5, 6
- active infection and low infection prevalence community: 1
- acute respiratory sars syndrome and admission screening: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute respiratory sars syndrome and louisville university: 1
- acute respiratory sars syndrome and low infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory sars syndrome and low infection prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute respiratory sars syndrome and low infection prevalence community: 1
- acute respiratory sars syndrome and low risk individual: 1, 2
- admission screening and low infection: 1, 2, 3, 4
- admission screening and low infection prevalence: 1, 2
- admission screening and low infection prevalence community: 1
Co phrase search for related documents, hyperlinks ordered by date